EUVIMEDEUVIMED entdecken
Crossref

A Versatile Bioorthogonal Theranostic Platform Enables Relay Activation of Tumor Cell Imaging and Targeted Protein Degradation

Feilong Sun, Tian Wang, Pengfei Wang, Jiaxin Shi, Yanyan Shen, Guilong Wang, Biyu Yang, Huiwen Li, Qiumeng Zhang, Yi Chen, Xuan Zhang iD

Journal of the American Chemical Society · 14.01.2026 · 148 (1) · 258-268

DOI: 10.1021/jacs.5c11564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 28.11.2025. Verfasst von Feilong Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery & Development Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Prodrugs, Proteolysis, Theranostic Nanomedicine, Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, Pioneer Hundred Talents Program of the Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation offers therapeutic promise but often suffers from on-target off-tissue toxicities. To overcome this challenge, we developed a versatile theranostic platform that integrates tumor cell imaging with precisely controlled protein degradation. Central to this platform is XZ2223, a glutathione (GSH)-cleavable bioorthogonal trigger that couples cancer cell labeling with concomitant tetrazine release, thereby activating trans-cyclooctene (TCO)-caged CRBN-recruiting degrader prodrugs, Pro-CC-885 and Pro-dBET6, to induce on-demand degradation of GSPT1 and BET, respectively. Coadministration of XZ2223 with either prodrug afforded robust tumor imaging and efficient protein degradation in xenograft models, while the XZ2223/Pro-dBET6 combination further elicited in vivo antitumor efficacy with reduced systemic toxicity. This innovative platform shows potential as a dual-function approach for precision cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsProteolysisTheranostic NanomedicineAntineoplastic AgentsNeoplasmsHumansAnimalsMiceCell Line, TumorOptical ImagingGlutathioneCyclooctanes

Substanzen

ProdrugsAntineoplastic AgentsGlutathioneCyclooctanes

Autor:innen und Institutionen

  • Drug Discovery & Development Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.

ORCID-Profile: Xuan Zhang

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Pioneer Hundred Talents Program of the Chinese Academy of Sciences

Zitieren

APA

Sun, F., Wang, T., Wang, P., Shi, J., Shen, Y., Wang, G., Yang, B., Li, H., Zhang, Q., Chen, Y., & Zhang, X. (2026). A Versatile Bioorthogonal Theranostic Platform Enables Relay Activation of Tumor Cell Imaging and Targeted Protein Degradation. Journal of the American Chemical Society, 148(1), 258-268. https://doi.org/10.1021/jacs.5c11564

Vancouver

Sun F, Wang T, Wang P, Shi J, Shen Y, Wang G, et al. A Versatile Bioorthogonal Theranostic Platform Enables Relay Activation of Tumor Cell Imaging and Targeted Protein Degradation. Journal of the American Chemical Society. 2026;148(1):258-268. doi:10.1021/jacs.5c11564

BibTeX
@article{Sun2026,
  author = {Sun, Feilong and Wang, Tian and Wang, Pengfei and Shi, Jiaxin and Shen, Yanyan and Wang, Guilong and Yang, Biyu and Li, Huiwen and Zhang, Qiumeng and Chen, Yi and Zhang, Xuan},
  title = {A Versatile Bioorthogonal Theranostic Platform Enables Relay Activation of Tumor Cell Imaging and Targeted Protein Degradation},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {1},
  pages = {258--268},
  doi = {10.1021/jacs.5c11564}
}
Kostenlos starten →